Presence and release of ATP from the retina in an Alzheimer's disease model.
暂无分享,去创建一个
[1] A. Guzman-Aranguez,et al. Nucleotides in the Eye: Focus on Functional Aspects and Therapeutic Perspectives , 2013, The Journal of Pharmacology and Experimental Therapeutics.
[2] J. Ávila,et al. Tau and neuron aging. , 2013, Aging and disease.
[3] R. Chang,et al. Review: Tauopathy in the retina and optic nerve: does it shadow pathological changes in the brain? , 2012, Molecular vision.
[4] M. Cordeiro,et al. Ocular Manifestations of Alzheimer's Disease in Animal Models , 2012, International journal of Alzheimer's disease.
[5] Keith L. Black,et al. Alzheimer’s Disease in the Retina: Imaging Retinal Aβ Plaques for Early Diagnosis and Therapy Assessment , 2012, Neurodegenerative Diseases.
[6] H. Petty,et al. Activation of P2X receptors induces apoptosis in human retinal pigment epithelium. , 2011, Investigative ophthalmology & visual science.
[7] B. Hyman,et al. Transgenic models of Alzheimer’s disease: Learning from animals , 2005, NeuroRX.
[8] Maho Shibata,et al. Involvement of P2X7 receptors in the hypoxia-induced death of rat retinal neurons. , 2010, Investigative ophthalmology & visual science.
[9] Z. Tan,et al. Amyloid-beta, the retina, and mouse models of Alzheimer disease. , 2010, The American journal of pathology.
[10] K. Jacobson,et al. Stimulation of the P2X7 receptor kills rat retinal ganglion cells in vivo. , 2008, Experimental eye research.
[11] E. Fletcher,et al. The role of purinergic receptors in retinal function and disease. , 2010, Advances in experimental medicine and biology.
[12] E. Fletcher,et al. Extracellular ATP induces retinal photoreceptor apoptosis through activation of purinoceptors in rodents , 2009, The Journal of comparative neurology.
[13] Colin L. Masters,et al. Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer’s disease , 2009, Graefe's Archive for Clinical and Experimental Ophthalmology.
[14] K. Ashe,et al. Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. , 2008, Investigative ophthalmology & visual science.
[15] A. Guzman-Aranguez,et al. Nucleotides in ocular secretions: their role in ocular physiology. , 2008, Pharmacology & therapeutics.
[16] H. Zimmermann. ATP and acetylcholine, equal brethren , 2008, Neurochemistry International.
[17] P. Zapata. Is ATP a suitable co-transmitter in carotid body arterial chemoreceptors? , 2007, Respiratory Physiology & Neurobiology.
[18] R. North,et al. Vesicular release of ATP at central synapses , 2006, Pflügers Archiv.
[19] J. Pintor,et al. Immunolocalisation of P2Y receptors in the rat eye , 2004, Purinergic Signalling.
[20] R. Jabs,et al. Identification of purinergic receptors in retinal ganglion cells. , 2001, Brain research. Molecular brain research.
[21] P. Illés,et al. Co-transmitter function of ATP in central catecholaminergic neurons of the rat , 2001, Neuroscience.
[22] F. LaFerla,et al. Transgenic Models of Alzheimer’s Disease , 2001 .
[23] R. Jabs,et al. Evidence for P2X3, P2X4, P2X5 but not for P2X7 containing purinergic receptors in Müller cells of the rat retina , 2000 .
[24] Y. Jo,et al. Synaptic corelease of ATP and GABA in cultured spinal neurons , 1999, Nature Neuroscience.
[25] R. Blanks,et al. Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina , 1996, Neurobiology of Aging.
[26] W. Volknandt,et al. Acetylcholine, ATP, and Proteoglycan Are Common to Synaptic Vesicles Isolated from the Electric Organs of Electric Eel and Electric Catfish as Well as from Rat Diaphragm , 1986, Journal of neurochemistry.
[27] N. Morel,et al. Simultaneous Release of Acetylcholine and ATP from Stimulated Cholinergic Synaptosomes , 1981, Journal of neurochemistry.
[28] P. Holton,et al. The possibility that ATP is a transmitter at sensory nerve endings. , 1953, The Journal of physiology.